Physician profile
Abraham John
NPI 1427811728
$1,187.80
in general payments reported to CMS, 2019-2025
16 companies · $1,086 in 2025
The $1,086 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $101 · 2025: $1,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $320.20 | 2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $164.73 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $162.75 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $137.63 | 2024-2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $96.75 | 2025 | Onpattro |
| Regeneron Healthcare Solutions, INC. | $37.60 | 2025 | Evkeeza |
| Amgen INC. | $35.50 | 2025 | Repatha |
| Agepha Pharma Fz LLC | $34.66 | 2025 | Lodoco |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.97 | 2025 | Jardiance |
| Lilly USA, LLC | $29.39 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.48 | 2025 | |
| Heartflow, INC. | $27.27 | 2025 | |
| Inspire Medical Systems, INC. | $21.70 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $21.24 | 2025 | Trelegy Ellipta |
| Esperion Therapeutics, INC. | $19.73 | 2025 | Nexletol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.